A Phase 1, Randomized, Double-Blind, Placebo- and Active- Controlled, Crossover Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Male and Female Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 May 2014
At a glance
- Drugs Acotiamide (Primary) ; Moxifloxacin
- Indications Bacterial infections; Dyspepsia
- Focus Pharmacodynamics
- Sponsors Astellas Pharma
- 16 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2009 Actual end date changed from Mar 2009 to Apr 2009 as reported by ClinicalTrials.gov.
- 12 Mar 2009 Planned number of patients changed from 72 to 80 as reported by ClinicalTrials.gov.